These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
410 related articles for article (PubMed ID: 32574963)
1. UVB induces cutaneous squamous cell carcinoma progression by de novo ID4 methylation via methylation regulating enzymes. Li L; Li F; Xia Y; Yang X; Lv Q; Fang F; Wang Q; Bu W; Wang Y; Zhang K; Wu Y; Shen J; Jiang M EBioMedicine; 2020 Jul; 57():102835. PubMed ID: 32574963 [TBL] [Abstract][Full Text] [Related]
2. Clinically relevant aberrant Filip1l DNA methylation detected in a murine model of cutaneous squamous cell carcinoma. Roth K; Coussement L; Knatko EV; Higgins M; Steyaert S; Proby CM; de Meyer T; Dinkova-Kostova AT EBioMedicine; 2021 May; 67():103383. PubMed ID: 34000624 [TBL] [Abstract][Full Text] [Related]
3. UVB-induced SFRP1 methylation potentiates skin damage by promoting cell apoptosis and DNA damage. Liang J; Liu L; Tang H; Ma Q; Sang Y; Kang X Exp Dermatol; 2022 Sep; 31(9):1443-1453. PubMed ID: 35657114 [TBL] [Abstract][Full Text] [Related]
4. Alterations of regulatory factors and DNA methylation pattern in thyroid cancer. Iancu IV; Botezatu A; Plesa A; Huica I; Fudulu A; Albulescu A; Bostan M; Mihaila M; Grancea C; Manda DA; Dobrescu R; Vladoiu SV; Anton G; Badiu CV Cancer Biomark; 2020; 28(2):255-268. PubMed ID: 32390600 [TBL] [Abstract][Full Text] [Related]
5. UV-type specific alteration of miRNA expression and its association with tumor progression and metastasis in SCC cell lines. Chen IP; Bender M; Spassova I; Henning S; Kubat L; Fan K; Degenhardt S; Mhamdi-Ghodbani M; Sriram A; Volkmer B; Boukamp P; Becker JC; Greinert R J Cancer Res Clin Oncol; 2020 Dec; 146(12):3215-3231. PubMed ID: 32865618 [TBL] [Abstract][Full Text] [Related]
6. Fibulin-3 Has Anti-Tumorigenic Activities in Cutaneous Squamous Cell Carcinoma. Wang X; Zhang Q; Li C; Qu X; Yang P; Jia J; Song L; Fan W; Jing H; Zheng Y J Invest Dermatol; 2019 Aug; 139(8):1798-1808.e5. PubMed ID: 30738056 [TBL] [Abstract][Full Text] [Related]
7. Huaier Inhibits Proliferation, Migration, and Invasion of Cutaneous Squamous Cell Carcinoma Cells by Inhibiting the Methylation Levels of CDKN2A and TP53. Wang L; Xu L; Wang Y Integr Cancer Ther; 2021; 20():15347354211031646. PubMed ID: 34291682 [TBL] [Abstract][Full Text] [Related]
8. Blocking the ATR-SerRS-VEGFA pathway targets angiogenesis for UV-induced cutaneous squamous cell carcinoma. Lu H; Peng Z; Zheng Z; Li C; Wang Y; Liang L; Chen Y; Zeng K Mol Carcinog; 2024 Jun; 63(6):1160-1173. PubMed ID: 38695641 [TBL] [Abstract][Full Text] [Related]
10. DNMT1-microRNA126 epigenetic circuit contributes to esophageal squamous cell carcinoma growth via ADAM9-EGFR-AKT signaling. Liu R; Gu J; Jiang P; Zheng Y; Liu X; Jiang X; Huang E; Xiong S; Xu F; Liu G; Ge D; Chu Y Clin Cancer Res; 2015 Feb; 21(4):854-63. PubMed ID: 25512445 [TBL] [Abstract][Full Text] [Related]
11. Tumor cell-specific AIM2 regulates growth and invasion of cutaneous squamous cell carcinoma. Farshchian M; Nissinen L; Siljamäki E; Riihilä P; Piipponen M; Kivisaari A; Kallajoki M; Grénman R; Peltonen J; Peltonen S; Quint KD; Bavinck JNB; Kähäri VM Oncotarget; 2017 Jul; 8(28):45825-45836. PubMed ID: 28526809 [TBL] [Abstract][Full Text] [Related]
12. DNMT1-targeting remodeling global DNA hypomethylation for enhanced tumor suppression and circumvented toxicity in oral squamous cell carcinoma. Liu Y; Sun Y; Yang J; Wu D; Yu S; Liu J; Hu T; Luo J; Zhou H Mol Cancer; 2024 May; 23(1):104. PubMed ID: 38755637 [TBL] [Abstract][Full Text] [Related]
13. Loss of retinoic acid receptor-related receptor alpha (Rorα) promotes the progression of UV-induced cSCC. Zhang G; Yan G; Fu Z; Wu Y; Wu F; Zheng Z; Fang S; Gao Y; Bao X; Liu Y; Wang X; Zhu S Cell Death Dis; 2021 Mar; 12(3):247. PubMed ID: 33664254 [TBL] [Abstract][Full Text] [Related]
14. Differentially methylated regions in T cells identify kidney transplant patients at risk for de novo skin cancer. Peters FS; Peeters AMA; Mandaviya PR; van Meurs JBJ; Hofland LJ; van de Wetering J; Betjes MGH; Baan CC; Boer K Clin Epigenetics; 2018; 10():81. PubMed ID: 29946375 [TBL] [Abstract][Full Text] [Related]
15. RBM3 Inhibits the Cell Cycle of Cutaneous Squamous Cell Carcinoma through the PI3K/AKT Signaling Pathway. Huang Y; Sun W; Zhu D; Liu L; Feng J; Yi Q Curr Mol Pharmacol; 2024; 17():e18761429323760. PubMed ID: 39041256 [TBL] [Abstract][Full Text] [Related]
16. GRIM-19 represses the proliferation and invasion of cutaneous squamous cell carcinoma cells associated with downregulation of STAT3 signaling. Wu N; Hui H; Cui L; Yang F Biomed Pharmacother; 2017 Nov; 95():1169-1176. PubMed ID: 28926927 [TBL] [Abstract][Full Text] [Related]
17. 3,6-Dihydroxyflavone regulates microRNA-34a through DNA methylation. Peng X; Chang H; Chen J; Zhang Q; Yu X; Mi M BMC Cancer; 2017 Sep; 17(1):619. PubMed ID: 28870206 [TBL] [Abstract][Full Text] [Related]
18. MYC deregulates TET1 and TET2 expression to control global DNA (hydroxy)methylation and gene expression to maintain a neoplastic phenotype in T-ALL. Poole CJ; Lodh A; Choi JH; van Riggelen J Epigenetics Chromatin; 2019 Jul; 12(1):41. PubMed ID: 31266538 [TBL] [Abstract][Full Text] [Related]
19. Complement C3a promotes proliferation, migration and stemness in cutaneous squamous cell carcinoma. Fan Z; Qin J; Wang D; Geng S J Cell Mol Med; 2019 May; 23(5):3097-3107. PubMed ID: 30825266 [TBL] [Abstract][Full Text] [Related]
20. DNMT1 in Li SY; Park J; Guan Y; Chung K; Shrestha R; Palmer MB; Susztak K J Am Soc Nephrol; 2019 Apr; 30(4):594-609. PubMed ID: 30850438 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]